By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Coffee & Health
Part of
Cardiovascular health
More information
Effects of coffee consumption
  1. Poole R, et al. (2017). Coffee consumption and health:umbrella review of meta-analyses of multiple health outcomes. BMJ. 22;359:j5024.
  2. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA). (2015). Scientific opinion on the safety of caffeine. EFSA Journal. 13(5):4102.
  3. Xie C, et al. (2018). Coffee consumption and risk of hypertension: a systematic review and dose-response meta-analysis of cohort studies. J Hum Hypertens. 32(2):83-93.
  4. Svatun ÅL, et al. (2022). Association between espresso coffee and serum total cholesterol: the Tromsø Study 2015-2016. Open Heart. 9(1):e001946.
  5. Ding M, et al (2014). Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circ. 129(6):643-59.
  6. Crippa A, et al. (2014). Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol.180(8):763-75.
  7.  Rodriguez Artalejo F & Lopez Garcia E. (2017).Coffee Consumption and Cardiovascular Disease: A condensed review of epidemiological evidence and mechanisms, JAgric Fd Chem. 66(21):5257-63.
  8. O’Keefe JH, et al. (2018). Coffee for cardioprotection and longevity. Prog Cardiovasc Dis.61(1):38-42.
  9. Ribeiro EM, et al. (2020). Safety of coffee consumption after myocardial infarction: A systematic review and meta-analysis .Nutr Metab Cardiovasc Dis.30(12):2146-58.
  10. Simon J, et al. (2021). Association of daily coffee consumption with cardiovascular health – results from the UK Biobank. Euro Heart J. 42:724;2416.
  11. Chieng D, et al. (2022). Effects of habitual coffee consumption on incident cardiovascular disease, arrhythmia, and mortality:findings from UK biobank. J Am Coll Cardiol. 79(9):1455.
  12. European Society of Cardiology (ESC). 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart Jour. 42:3227-337.
  13. Timmis A, et al. (2020). European Society of Cardiology: Cardiovascular. Disease statistics 2019. Euro Heart J. 41:12;85.
  14. European Heart Network, ‘European cardiovascular disease statistics 2017’. Available at:
  15. van Dam R. (2008). Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ. 337:a1440.
  16. Mozaffarian D, et al. (2008): Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circ. 117(23):3031-8.
  17. Bodar V, et al. (2020). Coffee consumption and risk of heart failure in the Physicians' Health study. Clin Nutr. ESPEN. 40:133-7.
  18. Stevens LM, et al. (2021). Association between coffee intake and incident heart failure risk: a machine learning analysis of the FHS,the ARIC Study, and the CHS Circulation: Heart Failure. 14:e006799.
  19. Hypponen E & Zhou A. (2021). Cardiovascular symptoms affect the patterns of habitual coffee consumption. Am J Clin Nutr. 114(1):214-9.
  20. van Dam RM, et al. (2020). Coffee, Caffeine, and Health. N Engl J Med. 383:369-78.
  21. van Dam RM & Hu FB. (2022). Caffeine consumption and cardiovascular health. Nat Rev Cardiol. 19:429–30.
  22. Tikhonoff V, et al. (2022).Prognostic cut-off values of caffeine and cardiovascular events in a cohort of unselected men and women from general population. Abstract presented at ESC congress.
  23. Xie C, et al. (2018). Coffee consumption and risk of hypertension: a systematic review and dose-response meta-analysis of cohort studies. J Hum Hypertens. 32(2):83-93.
  24. D’Elia L, et al. (2019). Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies. Eur J Nutr. 58(1):271-80.
  25. Surman S & Oparil S. (2021). Coffee and arterial hypertension. Curr Hypertens Rep. 23(7):38.
  26. Borghi C, et al. (2020). Nutraceuticals and blood pressure control: a European Society of Hypertension (EHJ) position document. J Hypertens. 38(5):799-812.
  27. Cai L, et al. (2012) The effect of coffee consumption on serum lipids: a meta-analysis of randomised controlled trials. Eur J Clin Nutr. 66(8):872-7.
  28. Svatun ÅL, et al. (2022). Association between espresso coffee and serum total cholesterol: the Tromsø Study 2015-2016. Open Heart. 9(1):e001946.
  29. Krittanawong C, et al. (2021). Is caffeine or coffee consumption a risk for new-onset atrial fibrillation? A systematic review and meta-analysis. Eur J Prev Cardiol. 28(12):e13-5.
  30. Buscemi S, et al. (2010): Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr. 64(5):483-9.
  31. Buscemi S, et al. (2010). Coffee and endothelial function: a battle between caffeine and antioxidants. Eur J Clin Nutr. 64:1242-3.
  32. Aqudelo-Ochoa GM. (2016). Coffee consumption increases the antioxidant capacity of plasma and has no effect on the lipid profile or vascular function in healthy adults in a randomized controlled trial. J Nutr. 146(3):524-31.
  33. Refsum H, et al. (2006). The Hordaland Homocysteine study: a community based study of homocysteine, its determinants, and associations with disease. J Nutr. 136:6(suppl);17731S-40S.
  34. Henkey GJ & Eikelboom JW. (1999). Homocysteine and vascular disease. Lancet. 354:407-13.
  35. Folsom AR, et al. (1998). Prospective study of coronary heart disease incidence in relation to fasting homocysteine, related polymorphisms, and B vitamins: the atherosclerosis risk in communities (ARIC) study. Circulation. 98:204-10.
  36. Fallon UB, et al. (2001). Homocysteine and coronary heart disease in the Caerphilly cohort: a 10-year follow up. Heart. 85:53-158.
  37. Higdon JV & Frei B. (2006). coffee and health: a review of recent human research. Crit Revs Fd Sci Nut. 46:101-23.
  38. Grubben MJ, et al. (2000). Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomised trial. AJCN. 71:448-84.
  39. Urgert RA, et al. (2000). Heavy coffee consumption and plasma homocysteine: a randomised controlled trial in healthy volunteers. AJCN. 72:1107-10.
  40. Christensen B, et al. (2001). Abstention from filtered coffee reduces concentrations of plasma homocysteine and serum cholesterol – a randomised controlled trial. AJCN. 74(3):302-7.
  41. Espositio F, et al. (2003): Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Aliment Pharmacol Therapy. 17:595-601.V
  42. Verhoef P, et al. (2002). Contribution of caffeine to the homocysteine-raising  effect of coffee: a randomised controlled trial in humans. AJCN. 76:1244-8.
  43. Olthof MR, et al. (2001). Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. AJCN. 7(737):532-8.
  44. Zhang W, et al. (2009). Coffee consumption and risk ofcardiovascular disease and all-cause mortality among men with type 2 diabetes. Diabetes Care. 32:1043-5.
  45. Mukanal KJ, et al. (2009): Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J. 157:495-501.
  46. Palatini P, et al. (2009). CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertension. 27(8):1594-601.
  47. Lopez-Garcia E, et al. (2016). Habitual coffee consumption and 24-hour blood pressure  control in older adults with hypertension. Clin Nutr. 35(6):1457-63.
  48. Notara V, et al. (2015). The role of coffee consumption on the 10-year (2004-2014) acute coronary syndrome (ACS) Incidence among cardiac patients: the GREECS observational study. Int J Fd Sci &Nutr. 66(6):722-8.
  49. Natella F, et al. (2002). Coffee drinking influences plasma antioxidant capacity in humans. Food Chem. 50:6211-16.
  50. Nystad T, et al. (2010). The effect of coffee consumption on serum total cholesterol in the Sami & Norwegian populations. Public Health Nutrition. 13(11):1818-25.
  51. Correa TAF, et al. (2013). Paper filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree. Nutrition. 29:977-81.
  52. Daneschvar HL, et al. (2021). Impact of coffee consumption on physiological markers of cardiovascular risk: a systematic review. Am J Med. 134(5):626-36;e2.
  53. Nehlig A. (2018). Inter individual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 70(2):384-411.




Latest research

All research

Information campaigns

All information campaigns